Company Name: Ascendis Pharma A/S

Ascendis Pharma A/S is a clinical stage biopharmaceutical company. The company is engaged in the development of long-acting prodrug therapies using its TransCon technology. The company’s lead product candidate is a treatment for growth hormone deficiency (GHD).

Ticker Symbol: ASND (NASDAQ)

Company Website:

Social Media: Ascendis Pharma LinkedIn

Headquarters: Copenhagen, Denmark